Macrophage Biomarkers CD68 and CD163 Correlate with NSCLC Patient Survival (Poster No. 1720 at #AACR2022)

Key Takeaways
  • Image analysis is able to use immune biomarkers to correlate immune cell presence and localization with patient survival in NSCLC.
  • Patient survival correlates with the presence or absence of CD68 and CD163 macrophage markers, but these markers do not match with traditional M1 (anti-tumor) or M2 (pro-tumor) phenotypes.
  • The use of image analysis technology can identify new biomarkers for better characterization of complex immune cell phenotypes.

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts